Month: July 2023

SAN CARLOS, Calif., July 10, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $7.50 per share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Iovance, are expected to be approximately $150 million. In addition, Iovance has granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock at the public offering price, less the underwriting discounts and commissions....

SAN DIEGO, July 10, 2023 (GLOBE NEWSWIRE) — American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its second quarter 2023 earnings in a press release to be issued after the market closes on Tuesday, July 25, 2023. Senior management will hold a conference call for its second quarter 2023 earnings on Wednesday, July 26, 2023 at 8:00 a.m. Pacific Time (“PT”). Conference call access information is as follows: Toll Free Number: 1 (800) 715-9871Conference ID: 7784863 A live on-demand audio webcast of the conference call will be available on the “Investor Relations” section of the Company’s website at www.americanassetstrust.com. A replay webcast will be available on the Company’s website approximately one hour after the conclusion of the conference call. About American Assets Trust, Inc. American Assets Trust, Inc. is...

TORONTO, July 10, 2023 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland”) (TSX: NPI) announces it will release its 2023 second quarter operating and financial results after markets close on Thursday, August 10, 2023. Northland’s management will hold an investor conference call and webcast at 10 a.m. Eastern Time (ET) on Friday, August 11, 2023, followed by a question and answer period with analysts. Conference call details: Date: Friday, August 11, 2023 Start Time: 10:00 a.m. ET Participants wishing to join the call and ask questions must register using the following URL below: https://register.vevent.com/register/BI4601ceef5c7a4348b73c48e8550ac53f For all other attendees, the call will be broadcast live on the internet, in listen-only mode and can be accessed using the following link: Webcast URL: https://edge.media-server.com/mmc/p/snhk5ze8 For...

— Clover’s leading respiratory vaccine franchise to be strengthened from commercial launch of quadrivalent influenza vaccine (AdimFlu-S [QIS]) in mainland China in H2-2023 — — Poised to be a leading RSV vaccine player in China with global potential by leveraging validated Trimer-Tag platform and GMP manufacturing capabilities — — Resilient cash balance of approximately RMB 1.5 billion as of June 30, 2023 compared to RMB 1.86 billion as of December 31, 2022, with approximately 50% reduction1 in operating expenditures achieved in H1-2023 compared to H1-2022; trend in increased operating efficiencies expected to continue over the next 12 months — SHANGHAI, China, July 11, 2023 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S. MONTREAL, July 10, 2023 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY) (“PyroGenesis” or the “Company”), is pleased to announce that it has amended certain terms of its previously announced “best-efforts” brokered private placement offering (the “Offering”) led by Research Capital Corporation as the sole agent and sole bookrunner (“Agent”), of up to 5,000 unsecured convertible debenture units of the Company (the “Convertible Debenture Units”) at a price of C$1,000 per Debenture Unit, for gross proceeds of up to C$5,000,000. In connection with the Offering, P. Peter Pascali, President, CEO, and Director intends to subscribe for up to C$2,000,000 of Convertible Debenture Units. Pursuant to the amended...

HOUSTON, July 10, 2023 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain second-quarter 2023 financial and operational results. This information is intended only to provide additional information regarding current estimates management believes will affect results for the second-quarter 2023. It is provided to assist investors, analysts, and others in formulating their own estimates, and is not intended to be a comprehensive presentation of all factors that will affect second-quarter 2023 results. Actual results and the impact of factors identified here may vary depending on the impact of other factors not identified here and are subject to finalization of the financial reporting process for second-quarter 2023.Estimated Average Realized Prices – 2Q23  Oil (bbl) NGL...

VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) will release its second quarter 2023 earnings results before market open on Thursday, July 27, 2023. A webcast to review the results will be held as follows:Date:Time:Listen-Only Webcast:Dial In for Investor & Analyst Q&A: Thursday, July 27, 20238:00 a.m. PT / 11:00 a.m. EThere416.915.3239 or 1.800.319.4610Quote “Teck Resources”, to join the call   An archive of the webcast will be available at teck.com within 24 hours. About TeckAs one of Canada’s leading mining companies, Teck is committed to responsible mining and mineral development with major business units focused on copper, zinc, and steelmaking coal. Copper, zinc and high-quality steelmaking coal are required for the transition...

VANCOUVER, BC, CANADA, July 10, 2023 (GLOBE NEWSWIRE) — Jolt Health Inc. (“JOLT” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) announced as per CSE policy, that is intends to close its previously announced non-brokered private placement financing on July 15th, 2023. The company will issue a total 6,984,266 units for gross proceeds of $100,125 at $0.0143 per unit. Each unit consists of one common share and one common share warrant.  Each warrant entitles the holder to subscribe for one additional common share for a period of 2 years from the date of closing at a price of $0.05, subject to the Corporation’s option to accelerate the expiry date if the stock trades at $0.15 for 10 trading days.   The company will pay finders fees of $1,125.25 and issue 87,500 brokers warrants in accordance with closing. About Jolt Health Inc. Jolt Health...

SS Innovations Invites Individual and Institutional Investors as Well as Advisors and Analysts, to Attend Its Real-time, Interactive Presentation at the Emerging Growth Conference FORT LAUDERDALE, FL, July 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it has been invited to present at the Emerging Growth Conference on Wednesday July 12, 2023 at 10:50 am ET. The Emerging Growth Conference is a live, interactive online event that gives existing shareholders and the investment community the opportunity to interact in real time with Dr. Sudhir Srivastava, CEO, Chairman and Founder of SS Innovations...